Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Net Margin
Nichi-Iko Pharmaceutical Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Net Margin |
-79%
|
| Country | US |
| Market Cap | 733.9B USD |
| Net Margin |
17%
|
| Country | DK |
| Market Cap | 4.1T DKK |
| Net Margin |
37%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Net Margin |
-4%
|
| Country | US |
| Market Cap | 370.3B USD |
| Net Margin |
45%
|
| Country | US |
| Market Cap | 331.5B USD |
| Net Margin |
4%
|
| Country | UK |
| Market Cap | 188.6B GBP |
| Net Margin |
13%
|
| Country | CH |
| Market Cap | 187.2B CHF |
| Net Margin |
20%
|
| Country | CH |
| Market Cap | 181.1B CHF |
| Net Margin |
30%
|
| Country | US |
| Market Cap | 163.3B USD |
| Net Margin |
-1%
|
| Country | FR |
| Market Cap | 113.2B EUR |
| Net Margin |
13%
|
Profitability Report
View the profitability report to see the full profitability analysis for Nichi-Iko Pharmaceutical Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Nichi-Iko Pharmaceutical Co Ltd's most recent financial statements, the company has Net Margin of -78.8%.
You don't have any saved screeners yet
